Modernizing the good faith inquiry process

Kalderos Review is an easy-to-use tool that allows manufacturers to work with 340B covered entities in “good faith” to validate suspected duplicate discounts.

Respond to manufacturers quickly and efficiently

Kalderos collects data from multiple manufacturers and payers so you don’t have to, and houses everything you need to confirm suspected noncompliance within the Review tool.

Ensure drug discount program compliance

Review serves as a single source of information to reduce the complexity and administrative burden of compliance, expediting the good faith inquiry process to support program integrity.

Review benefits
An industry-leading solution to support your covered entity
Collaboration with all stakeholders
Collaboration is crucial to ensure 340B compliance. Review allows teams to work together and with outside partners to provide responses to good faith inquiries.
Historical datasets at your fingertips
Support your compliance recordkeeping with documentation and details of all prior responses, which are easily accessible within your Review account.
Algorithm
A single touchpoint for your good faith inquiries
We leverage our industry-leading algorithm to identify claims for review, placing them all in a single platform.
A source of comprehensive data
Kalderos continuously analyzes and brings together data from your state Medicaid agency and pharmaceutical manufacturers.
Review features

The tools your team needs to complete good faith inquiries

About good faith inquiries

Good faith inquiries are an important part of ensuring 340B Program integrity. Are good faith inquiries the same as audits? No. Rather, they are "good faith" attempts to resolve concerns related to duplicate discounts. HRSA encourages these type of "good faith" collaborations. Here are some examples of HRSA guidance:

Per HRSA's proposed omnibus guidance: "A manufacturer should work in good faith with a covered entity to resolve any concerns related to duplicate discounts and diversion of 340B drugs before requesting HHS approval to audit the covered entity." 

Per the 1996 audit guidelines: "The manufacturer and the covered entity must make a good faith effort to resolve the issue ..."
What's next

Join us, and start  managing your good faith inquiries

Get in touch
Get started with Kalderos Review
By submitting this form, I agree that Kalderos.com may contact me at the email address above to tell me about its services.
Thank you! Your submission has been received.
We will get back to you shortly.
Oops! Something went wrong while submitting the form.
All your good faith inquiries, one convenient tool.
Collaboration with all stakeholders
A single touchpoint for your good faith inquiries
Historical datasets at your fingertips
A source of comprehensive data
Contact us
Support

Contact Kalderos’ customer support for help with your account.

Sales

Learn more about our Drug Discount Management solutions.

Media

Find out how we’re redefining how the business of healthcare performs.